Internationally Known Alzheimer’s Researcher to Speak at Southeast in October


Photo of Dr. Barry Reisberg

Dr. Barry Reisberg will speak Oct. 19 at Southeast Missouri State University. His presentation is titled “Life’s Mirror: New Ways of Understanding and Treating Alzheimer’s Disease.”


Oct. 5, 2006 – Dr. Barry Reisberg, internationally known for Alzheimer’s disease research, will speak Oct. 19 at Southeast Missouri State University.

This free event, presented by the Southeast Missouri Hospital Foundation in cooperation with Southeast Missouri State University and the Alzheimer’s Association, will be held from 6 to 8 p.m. in Glenn Auditorium of Robert A. Dempster Hall.

Reisberg’s presentation is titled “Life’s Mirror: New Ways of Understanding and Treating Alzheimer’s Disease.”

Prior to Reisberg’s presentation, participants are invited to enjoy refreshments and view exhibits. A reception will follow his presentation.

Pre-registration is required. To register, call Southeast Missouri Hospital’s Generations Family Resource Center at (573) 651-5825.  Learn more about Reisberg’s work online at

The program has been approved for 2.0 contact hours. Southeast Missouri Hospital is an approved provider of continuing nursing education by the Missouri Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Reisberg is clinical director of the New York University School of Medicine’s Silberstein Aging and Dementia Research Center, a federally-funded, research and service facility dedicated to increased knowledge and improved treatment of Alzheimer’s and related disorders of late life.

A geriatric psychiatrist, he is professor of psychiatry at the New York University (NYU) School of Medicine. He is also director of the Zachary and Elizabeth M. Fisher Alzheimer’s Disease Education and Resources Program at NYU and an adjunct professor in the faculty of medicine at McGill University in Montreal, Canada. He is the author of A Guide To Alzheimer’s Disease, and has authored or co-authored more than 250 scientific and medical papers and chapters in textbooks. He has been awarded six U.S. patents for his discoveries.

Reisberg’s work has played a pivotal role in the development and approval of all three major drugs used in the treatment of Alzheimer’s disease. His clinical descriptions of the progression of Alzheimer’s disease and dementia are in wide use around the world and have been used at pivotal measures in the approval of Alzheimer’s disease treatments.

Alzheimer’s Association statistics show that an estimated 4.5 million Americans suffer from Alzheimer’s disease, and that one in three Americans know someone with the disease. Almost one in two people over the age of 85 have some degree of Alzheimer’s. The annual national direct and indirect costs associated with caring for people with Alzheimer’s disease is $100 billion.